Outcomes: we expect to demonstrate at the end of the study that modification of the diet prevents weight gain in Rosiglitazone treated patients and to offer the optimal dietary interventions that could be applied in TZD-treated patients to minimize weight gain while effectively treating DM and insulin resistance.